See original story here Densitas Inc. announced today that it has received regulatory clearance for its automated breast density software, DM-Density. DM-Density has received regulatory clearance from the Australian Therapeutic Goods Administration (TGA) and will be available through the EnvoyAI Platform. Australia has approximately 12 million women and 1.7 million are screened for breast cancer…

Densitas Enters Australian Market with Machine Learning Technology for Breast Health HALIFAX, Canada – February 27, 2018 – Densitas Inc. announced today that it has received regulatory clearance for its automated breast density software, DM-Density. DM-Density has received regulatory clearance from the Australian Therapeutic Goods Administration (TGA) and will be available through the EnvoyAI Platform….

See original story here ABK Biomedical has raised more than $9 million in an over-subscribed round of equity funding that closed last August.  The larger equity base has allowed the company to borrow $3 million from the Atlantic Innovation Fund. The Halifax-based medical device maker revealed that it closed the Series A funding round – one…

See original story here When Jean-Paul Deveau returned home to Nova Scotia in 1981 on summer break from McGill University, he discovered he had no bedroom. “I’m about to go put my stuff in my room and my mother stops me and says, ‘So, before you go upstairs . . . your father started a business and he’s running…

University of Manchester Research Finds Densitas’ Breast Density Software Demonstrates a Strong Association with Breast Cancer Risk HALIFAX, Canada – February 20, 2018 – Researchers from the University of Manchester have published a review of breast density measurement methods in the journal Breast Cancer Research. The study clinically validates Densitas’ automated breast density measurement software…

See original story here When Jean-Paul Deveau returned home to Nova Scotia in 1981 on summer break from McGill University, he discovered he had no bedroom. “I’m about to go put my stuff in my room and my mother stops me and says, ‘So, before you go upstairs . . . your father started a business and he’s running…

See original story here Halifax drug discovery company Appili Therapeutics Inc., has raised $4.3 million in equity financing to further its operations and add to its number of drug candidates. The company said in a press release it raised the money through a private placement, which was over-subscribed. It received money from new and existing investors, including Innovacorp,…

2015 © Copyright - Bionova